Free Access
Med Sci (Paris)
Volume 30, Number 6-7, Juin–Juillet 2014
Page(s) 633 - 635
Section Nouvelles
Published online 11 July 2014
  1. Gory-Fauré S, Prandini MH, Pointu H, et al. Role of vascular endothelial-cadherin in vascular morphogenesis. Development 1999 ; 126 : 2093–2102. [PubMed] [Google Scholar]
  2. Wallez Y, Cand F, Cruzalegui F, et al. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene 2007 ; 26 : 1067–1077. [CrossRef] [PubMed] [Google Scholar]
  3. Lambeng N, Wallez Y, Rampon C, et al. Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues. Circ Res 2005 ; 96 : 384–391. [CrossRef] [PubMed] [Google Scholar]
  4. Sidibé A, Polena H, Razanajatovo J, et al. VE-cadherin Y685F knock-in mouse is sensitive to vascular permeability in recurrent angiogenic organs. AJP-Heart Circ Physiol 2014 (sous presse). [Google Scholar]
  5. Vilgrain I, Pelletier L, Cand F. Patent application N° WO2008062314, 2008. [Google Scholar]
  6. Cicardi M, Levy RJ, McNeil DL, et al. Ecallantide for the treatment of acute attacks in hereditary angioedema. N Engl J Med 2010 ; 363 : 523–531. [CrossRef] [PubMed] [Google Scholar]
  7. Bouillet L, Mannic T, Arboleas M, et al. Hereditary angioedema: key role for kallikrein and bradykinin in vascular endothelial-cadherin cleavage and edema formation. J Allergy Clin Immunol 2011 ; 128 : 232–234. [CrossRef] [PubMed] [Google Scholar]
  8. Guillemin F, Saraux A, Guggenbuhl P, et al. Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis 2005 ; 64 : 1427–1430. [CrossRef] [PubMed] [Google Scholar]
  9. Sidibé A, Mannic T, Arboleas M, et al. Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor α-induced VE-cadherin cleavage. Arthritis Rheum 2012 ; 64 : 77–87. [CrossRef] [PubMed] [Google Scholar]
  10. Corada M, Zanetta L, Orsenigo F, et al. A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability. Blood 2002 ; 100 : 905–911. [CrossRef] [PubMed] [Google Scholar]
  11. Bouillet L, Baudet AE, Deroux A, et al. Auto-antibodies to vascular endothelial cadherin in humans: association with autoimmune diseases. Lab Invest 2013 ; 93 : 1194–1202. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.